Go offline with the Player FM app!
Could you give up caffeine for six months?
Manage episode 520528695 series 73
No coffee for six months, not even decaf. That's what participants of a trial looking into the effect on atrial fibrillation were asked to do.
Also, could we be on the verge of changing guidelines for asthma care in children? Or is it too early to call?
And catching cancer early can be important. How far away are we from harnessing blood, urine and even saliva tests to help?
References
- PFAS inquiry hands down 47 recommendations to better regulate 'forever chemicals' in Australia - ABC News
- The Lancet series on ultra-processed foods
- Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
- Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial
- Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial
646 episodes
Manage episode 520528695 series 73
No coffee for six months, not even decaf. That's what participants of a trial looking into the effect on atrial fibrillation were asked to do.
Also, could we be on the verge of changing guidelines for asthma care in children? Or is it too early to call?
And catching cancer early can be important. How far away are we from harnessing blood, urine and even saliva tests to help?
References
- PFAS inquiry hands down 47 recommendations to better regulate 'forever chemicals' in Australia - ABC News
- The Lancet series on ultra-processed foods
- Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
- Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial
- Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial
646 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.